Los Angeles Capital Management LLC Fulcrum Therapeutics, Inc. Transaction History

Los Angeles Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$5.98 - $9.31 $125,807 - $195,863	21,038 New	21,038 $130,000
Q1 2021 May 05, 2021	SELL	$10.94 - $15.32 $227,081 - $317,997	-20,757 Closed	0 $0
Q4 2020 Feb 04, 2021	SELL	$7.84 - $13.4 $83,989 - $143,554	-10,713 Reduced 34.04%	20,757 $243,000
Q3 2020 Nov 02, 2020	BUY	$7.22 - $20.7 $114,733 - $328,943	15,891 Added 102.0%	31,470 $250,000
Q2 2020 Aug 05, 2020	BUY	$9.11 - $22.06 $45,094 - $109,197	4,950 Added 46.57%	15,579 $284,000
Q1 2020 May 04, 2020	BUY	$9.49 - $21.26 $100,869 - $225,972	10,629 New	10,629 $127,000

150

52.2M

6.91M

1.9M

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $173M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.